(Q44303560)

1 December 2017

title

Effects of cytidine 5'-diphosphocholine on plasma homocysteine levels in rat. (English)

1 reference

1 December 2017

Rosa Giménez

1

1 reference

1 December 2017

Juan Aguilar

series ordinal

2

1 reference

1 December 2017

publication date

1 February 2003

1 reference

Comparative Biochemistry and Physiology B

1 December 2017

published in

1 reference

1 December 2017

volume

134

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

271-276

1 reference

Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

Citicoline (CDP-choline): mechanisms of action and effects in ischemic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

The metabolism of homocysteine: pathways and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

Effects of CDP-choline administration on brain striatum platelet-activating factor in aging rats

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

Cytidine (5') diphosphocholine-induced decrease in cerebral platelet activating factor is due to inactivation of its synthesizing enzyme cholinephosphotransferase in aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

Cytidine diphosphate choline administration activates brain cytidine triphosphate: phosphocholine cytidylytransferase in aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

Homocysteine and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

Lipid-lowering drugs and homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

Evidence that 5′-Cytidinediphosphocholine Can Affect Brain Phospholipid Composition by Increasing Choline and Cytidine Plasma Levels

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

Community-living nonagenarians in Northern Ireland have lower plasma homocysteine but similar methylenetetrahydrofolate reductase thermolabile genotype prevalence compared to 70–89-year-old subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

Homocysteine and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

Choline and human nutrition.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-4959%2802%2900258-0

7 January 2021

10.1016/S1096-4959(02)00258-0

Identifiers

DOI

1 reference

1 December 2017

1 reference